Iron Sucrose Injection shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting May 21, 2026 · last update May 21, 2026
Manufacturers: Mylan Institutional, a Viatris Company
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Iron Sucrose, Injection, 50 mg/2.5 mL (NDC 67457-957-99) | Mylan Institutional, a Viatris Company | To Be Discontinued | — | A business decision has been made to discontinue of 2.5mL presentation only. Continuity of supply is forecasted across all other presentations of Iron Sucrose: 67457-639-10 Iron Sucrose 20mg/mL 10mL SDV 5PK 67457-638-10 Iron Sucrose 20mg/mL 5mL SDV 10PK 67457-638-25 Iron Sucrose 20mg/mL 5mL SDV 25PK. | Posted May 21, 2026 Updated May 21, 2026 Discontinued May 21, 2026 |